{
    "title": "Identification of Causal Relationship between Amyloid-beta Accumulation and Alzheimer's Disease Progression via Counterfactual Inference. (arXiv:2307.01389v1 [cs.LG])",
    "abstract": "Alzheimer's disease (AD) is a neurodegenerative disorder that is beginning with amyloidosis, followed by neuronal loss and deterioration in structure, function, and cognition. The accumulation of amyloid-beta in the brain, measured through 18F-florbetapir (AV45) positron emission tomography (PET) imaging, has been widely used for early diagnosis of AD. However, the relationship between amyloid-beta accumulation and AD pathophysiology remains unclear, and causal inference approaches are needed to uncover how amyloid-beta levels can impact AD development. In this paper, we propose a graph varying coefficient neural network (GVCNet) for estimating the individual treatment effect with continuous treatment levels using a graph convolutional neural network. We highlight the potential of causal inference approaches, including GVCNet, for measuring the regional causal connections between amyloid-beta accumulation and AD pathophysiology, which may serve as a robust tool for early diagnosis and ",
    "link": "http://arxiv.org/abs/2307.01389",
    "context": "Title: Identification of Causal Relationship between Amyloid-beta Accumulation and Alzheimer's Disease Progression via Counterfactual Inference. (arXiv:2307.01389v1 [cs.LG])\nAbstract: Alzheimer's disease (AD) is a neurodegenerative disorder that is beginning with amyloidosis, followed by neuronal loss and deterioration in structure, function, and cognition. The accumulation of amyloid-beta in the brain, measured through 18F-florbetapir (AV45) positron emission tomography (PET) imaging, has been widely used for early diagnosis of AD. However, the relationship between amyloid-beta accumulation and AD pathophysiology remains unclear, and causal inference approaches are needed to uncover how amyloid-beta levels can impact AD development. In this paper, we propose a graph varying coefficient neural network (GVCNet) for estimating the individual treatment effect with continuous treatment levels using a graph convolutional neural network. We highlight the potential of causal inference approaches, including GVCNet, for measuring the regional causal connections between amyloid-beta accumulation and AD pathophysiology, which may serve as a robust tool for early diagnosis and ",
    "path": "papers/23/07/2307.01389.json",
    "total_tokens": 980,
    "translated_title": "通过逆向推断识别淀粉样蛋白β积累与阿尔茨海默病进展之间的因果关系",
    "translated_abstract": "阿尔茨海默病（AD）是一种神经退行性疾病，始于淀粉样蛋白β沉积，随后引发神经元丢失和结构、功能以及认知的恶化。通过18F-florbetapir (AV45) 正电子发射断层摄影（PET）成像测量的淀粉样蛋白β在大脑中的积累已被广泛应用于AD的早期诊断。然而，淀粉样蛋白β积累与AD病理生理之间的关系仍不清楚，因此需要因果推断方法来揭示淀粉样蛋白β水平如何影响AD的发展。在本文中，我们提出了一种用于估计连续治疗水平下个体治疗效果的图形变系数神经网络（GVCNet），使用了图卷积神经网络。我们强调了因果推断方法，包括GVCNet，在测量淀粉样蛋白β积累与AD病理生理之间的区域因果连接方面的潜力，这可能成为早期诊断和治疗的强大工具。",
    "tldr": "通过逆向推断方法揭示淀粉样蛋白β积累与阿尔茨海默病之间的因果关系，有助于早期诊断和治疗。"
}